Home › Companies › ADC Therapeutics SA › 2025-2026

ADC Therapeutics SA 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and ADC Therapeutics SA’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

48Reported items
122Asset managers
2,191Fund votes
2026-06-01Meeting date

Proxy season: 2025-2026

Explore ADC Therapeutics SA in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by ADC Therapeutics SA

These tallies are ADC Therapeutics SA’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ADC Therapeutics SA — official shareholder meeting results, meeting held 2026-06-01
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Proposal #2 : Approving, on an advisory basis under Swiss law, the compensation report The shareholders approved, in a non-binding advisory vote, the compensation report for the year ended December 31, 2025.	64,289,299	1,242,782	3,815,289	--	14,253,584	Majority: yes
Proposal #3 : Discharging the members of the board of directors and the executive committee from liability The shareholders approved that the members of the board of directors and the executive committee be discharged from liability for the	63,695,590	86,523	3,966,182	--	14,253,584	Majority: yes
Proposal #4 : Approving the appropriation of the financial results The shareholders approved that the net loss for the year ended December 31, 2025 be carried forward.	79,774,946	8,511	3,817,497	--	--	Majority: yes
Elect Director: Ron Squarer	65,109,377	416,194	3,821,799	--	14,253,584	Majority: yes
Elect Director: Robert Azelby	65,094,726	429,835	3,822,809	--	14,253,584	Majority: yes
Elect Director: Jean-Pierre Bizzari	63,631,611	1,852,731	3,863,025	--	14,253,587	Majority: yes
Elect Director: Timothy Coughlin	65,198,947	327,049	3,821,374	--	14,253,584	Majority: yes
Elect Director: Peter Hug	64,927,601	556,545	3,863,224	--	14,253,584	Majority: yes
Elect Director: Ameet Mallik	65,133,390	387,036	3,826,944	--	14,253,584	Majority: yes
Elect Director: Viviane Monges	64,918,973	556,772	3,871,625	--	14,253,584	Majority: yes
Elect Director: Tyrell Rivers	64,796,462	729,534	3,821,374	--	14,253,584	Majority: yes
Elect Director: Victor Sandor	65,151,213	373,932	3,822,225	--	14,253,584	Majority: yes
Elect Director: Robert Azelby	65,136,589	388,421	3,822,360	--	14,253,584	Majority: yes
Elect Director: Peter Hug	65,014,833	469,178	3,863,359	--	14,253,584	Majority: yes
Elect Director: Victor Sandor	65,145,109	380,752	3,821,509	--	14,253,584	Majority: yes
Proposal #7 : Reelecting the Independent Proxy The shareholders reelected PHC Notaires, in Lausanne, Switzerland, as the Independent Proxy for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual	79,756,534	17,712	3,826,708	--	--	Majority: yes
Proposal #8 : Reelecting the auditors The shareholders reelected PricewaterhouseCoopers SA as the statutory auditor and independent registered public accounting firm for the year ending December 31, 2026.	79,747,180	31,325	3,822,449	--	--	Majority: yes
Proposal #9 : Approving, on a binding basis under Swiss law, the compensation of the board of directors and the executive committee The shareholders approved, on a binding basis under Swiss law, that (i) the maximum aggregate amount of comp	48,456,972	16,977,874	3,912,524	--	14,253,584	Majority: yes
Proposal #10 : Approving, on an advisory basis under U.S. law, the compensation paid to the named executive officers The shareholders approved, on an advisory basis under U.S.	64,172,306	1,271,205	3,903,859	--	14,253,584	Majority: yes
Proposal #11 : Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The shareholders approved an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan.	46,624,648	18,904,924	3,817,798	--	14,253,584	Majority: yes
Proposal #12 : Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capit	48,485,517	17,043,416	3,818,437	--	14,253,584	Majority: yes

Source: ADC Therapeutics SA, Form 8-K — read the filing on EDGAR.

How asset managers voted at the ADC Therapeutics SA 2025-2026 meeting

Each item below shows how the 122 asset managers that disclosed a ADC Therapeutics SA vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADC Therapeutics SA’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers The Board of Directors proposes that the following proposal: "RESOLVED, that the Company's Shareholders approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in "Executive Compensation" and the related compensation tables and narrative disclosure i

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 15 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 64,172,306AGAINST: 1,271,205

ADC Therapeutics SA’s own tally for this item (“Proposal #10 : Approving, on an advisory basis under U.S. law, the compensation paid to the named executive officers The shareholders approved, on an advisory basis under U.S.”): 64,172,306 for, 1,271,205 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 50.5% for, 1.0% against (51.5% of the company cast a for/against vote).

The 118 asset managers below cast 98% of the shares they voted on this item FOR (44,109,448 for, 745,981 against).

FOR 91%8%

FOR: 44,109,448 (90.7%)AGAINST: 745,981 (1.5%)ABSTAIN: 3,800,194 (7.8%)

Largest asset managers voting on “Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers The Boar” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Abstain	Vote
Redmile Group, LLC	12,681,731	0	0	For
BlackRock	5,842,192	1,199	0	For
MUTUAL FUND SERIES TRUST	5,701,655	0	0	For
Prosight Management, LP	3,533,324	0	0	For
Point72	3,257,237	0	0	For
OAKTREE CAPITAL MANAGEMENT LP	0	0	2,623,133	Abstain
Caligan Partners LP	1,805,000	0	0	For
State Street	1,366,614	7,611	0	For
Vanguard	1,208,057	0	0	For
Oaktree Fund Advisors, LLC	0	0	1,176,861	Abstain
PLATINUM INVESTMENT MANAGEMENT LTD	934,491	0	0	For
Corient Private Wealth LP	694,801	0	0	For
Two Sigma	565,441	0	0	For
Northern Trust	495,172	5,356	0	For
PANAGORA ASSET MANAGEMENT INC	464,389	0	0	For
Charles Schwab	448,722	0	0	For
ACADIAN ASSET MANAGEMENT LLC	384,695	0	0	For
Lazard	0	341,943	0	Against
BOOTHBAY FUND MANAGEMENT, LLC	333,312	0	0	For
Goldman Sachs	328,073	0	0	For
ORBIMED ADVISORS LLC	321,100	0	0	For
MELLON INVESTMENTS Corp	0	314,482	0	Against
DE Shaw	283,041	0	0	For
Fidelity	272,664	0	0	For
Russell Investments	272,596	0	0	For

Showing the 25 largest of 118 asset managers. See all 118 in the interactive database.

2. Approving, on an advisory basis under Swiss law, the Company's Compensation Report for the year ended December 31, 2025. The Board of Directors proposes that the Company's Compensation report for the year ended December 31, 2025, be approved in a non-binding advisory vote.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 64,289,299AGAINST: 1,242,782

ADC Therapeutics SA’s own tally for this item (“Proposal #2 : Approving, on an advisory basis under Swiss law, the compensation report The shareholders approved, in a non-binding advisory vote, the compensation report for the year ended December 31, 2025.”): 64,289,299 for, 1,242,782 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 50.5% for, 1.0% against (51.5% of the company cast a for/against vote).

The 42 asset managers below cast 99.9% of the shares they voted on this item FOR (14,351,762 for, 1,199 against).

FOR 99.9%

FOR: 14,351,762 (100.0%)AGAINST: 1,199 (0.0%)

Largest asset managers voting on “Approving, on an advisory basis under Swiss law, the Company's Compensation Report for the year ended December” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
BlackRock	5,842,192	1,199	For
MUTUAL FUND SERIES TRUST	5,701,655	0	For
Vanguard	1,086,732	0	For
Charles Schwab	224,361	0	For
Equitable	185,783	0	For
QUANTITATIVE MASTER SERIES LLC	173,365	0	For
Florida Trust Wealth Management Co	150,435	0	For
TIAA	123,269	0	For
State Street	115,544	0	For
Russell Investments	90,968	0	For
Fidelity	87,048	0	For
DAFNA Capital Management LLC	72,081	0	For
Lincoln Financial	53,800	0	For
AIG/SunAmerica	52,249	0	For
Northern Trust	48,191	0	For
Global X	48,046	0	For
Pacific Life	34,502	0	For
AQR	30,581	0	For
CLEARWATER INVESTMENT TRUST	30,175	0	For
Brighthouse	29,514	0	For
Nationwide	24,436	0	For
John Hancock	24,311	0	For
Bridge Builder Trust	19,177	0	For
Voya	17,395	0	For
ProShares	15,108	0	For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

3. Approving the appropriation of the financial results for the year ended December 31, 2025 by carrying forward the loss resulting from such year. The Board of Directors proposes that the net loss for the year ended December 31, 2025, be carried forward.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 79,774,946AGAINST: 8,511

ADC Therapeutics SA’s own tally for this item (“Proposal #4 : Approving the appropriation of the financial results The shareholders approved that the net loss for the year ended December 31, 2025 be carried forward.”): 79,774,946 for, 8,511 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 63% for, 0.1% against (63% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (11,551,079 for, 0 against).

FOR 100%

FOR: 11,551,079 (100.0%)

Largest asset managers voting on “Approving the appropriation of the financial results for the year ended December 31, 2025 by carrying forward ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

4. Reelecting PHC Notaires, in Lausanne, Switzerland, as the Independent Proxy The Board of Directors proposes that PHC Notaires, in Lausanne, Switzerland be reelected as the Independent Proxy for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of Shareholders.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 79,756,534AGAINST: 17,712

ADC Therapeutics SA’s own tally for this item (“Proposal #7 : Reelecting the Independent Proxy The shareholders reelected PHC Notaires, in Lausanne, Switzerland, as the Independent Proxy for a one-year term, beginning as of the Annual Meeting and ending at the closing”): 79,756,534 for, 17,712 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 63% for, 0.1% against (63% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (11,551,079 for, 0 against).

FOR 100%

FOR: 11,551,079 (100.0%)

Largest asset managers voting on “Reelecting PHC Notaires, in Lausanne, Switzerland, as the Independent Proxy The Board of Directors proposes th” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

5. Reelecting nominees to the Board of Directors: The board of directors proposes that Ameet Mallik be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 65,133,390AGAINST: 387,036

ADC Therapeutics SA’s own tally for this item (“Elect Director: Ameet Mallik”): 65,133,390 for, 387,036 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 51.2% for, 0.4% against (51.5% of the company cast a for/against vote).

The 36 asset managers below cast 99.9% of the shares they voted on this item FOR (11,550,482 for, 597 against).

FOR 99.9%

FOR: 11,550,482 (100.0%)AGAINST: 597 (0.0%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Ameet Mallik be reelected ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

6. Reelecting nominees to the Board of Directors: The board of directors proposes that Jean-Pierre Bizzari be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 63,631,611AGAINST: 1,852,731

ADC Therapeutics SA’s own tally for this item (“Elect Director: Jean-Pierre Bizzari”): 63,631,611 for, 1,852,731 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 50.1% for, 1% against (51.5% of the company cast a for/against vote).

The 36 asset managers below cast 98% of the shares they voted on this item FOR (11,241,928 for, 283,831 against).

FOR 97%

FOR: 11,241,928 (97.3%)AGAINST: 283,831 (2.5%)ABSTAIN: 25,320 (0.2%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Jean-Pierre Bizzari be ree” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Abstain	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	0	For
BlackRock	3,275,660	0	0	For
Vanguard	1,086,732	0	0	For
Charles Schwab	224,361	0	0	For
Equitable	160,463	0	25,320	For
QUANTITATIVE MASTER SERIES LLC	173,365	0	0	For
TIAA	0	123,269	0	Against
State Street	115,544	0	0	For
Russell Investments	0	90,968	0	Against
Fidelity	87,048	0	0	For
Lincoln Financial	53,800	0	0	For
AIG/SunAmerica	52,249	0	0	For
Northern Trust	48,191	0	0	For
Global X	0	48,046	0	Against
Pacific Life	34,502	0	0	For
AQR	30,581	0	0	For
CLEARWATER INVESTMENT TRUST	30,175	0	0	For
Brighthouse	29,514	0	0	For
Nationwide	24,436	0	0	For
John Hancock	24,311	0	0	For
Bridge Builder Trust	19,177	0	0	For
Voya	17,395	0	0	For
ProShares	15,108	0	0	For
DWS	14,248	0	0	For
T. Rowe Price	11,619	0	0	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

7. Reelecting nominees to the Board of Directors: The board of directors proposes that Timothy Coughlin be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 65,198,947AGAINST: 327,049

ADC Therapeutics SA’s own tally for this item (“Elect Director: Timothy Coughlin”): 65,198,947 for, 327,049 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 51.3% for, 0.3% against (51.5% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (11,551,079 for, 0 against).

FOR 100%

FOR: 11,551,079 (100.0%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Timothy Coughlin be reelec” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

8. Reelecting nominees to the Board of Directors: The board of directors proposes that Tyrell Rivers be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 64,796,462AGAINST: 729,534

ADC Therapeutics SA’s own tally for this item (“Elect Director: Tyrell Rivers”): 64,796,462 for, 729,534 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 50.9% for, 0.6% against (51.5% of the company cast a for/against vote).

The 36 asset managers below cast 99.9% of the shares they voted on this item FOR (11,550,482 for, 597 against).

FOR 99.9%

FOR: 11,550,482 (100.0%)AGAINST: 597 (0.0%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Tyrell Rivers be reelected” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

9. Reelecting nominees to the Board of Directors: The board of directors proposes that Viviane Monges be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 64,918,973AGAINST: 556,772

ADC Therapeutics SA’s own tally for this item (“Elect Director: Viviane Monges”): 64,918,973 for, 556,772 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 51.0% for, 0.5% against (51.5% of the company cast a for/against vote).

The 36 asset managers below cast 99% of the shares they voted on this item FOR (11,395,034 for, 130,725 against).

FOR 99%

FOR: 11,395,034 (98.6%)AGAINST: 130,725 (1.1%)ABSTAIN: 25,320 (0.2%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Viviane Monges be reelecte” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Abstain	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	0	For
BlackRock	3,275,660	0	0	For
Vanguard	1,086,732	0	0	For
Charles Schwab	224,361	0	0	For
Equitable	160,463	0	25,320	For
QUANTITATIVE MASTER SERIES LLC	173,365	0	0	For
TIAA	0	123,269	0	Against
State Street	115,544	0	0	For
Russell Investments	90,968	0	0	For
Fidelity	87,048	0	0	For
Lincoln Financial	53,800	0	0	For
AIG/SunAmerica	52,249	0	0	For
Northern Trust	48,191	0	0	For
Global X	48,046	0	0	For
Pacific Life	34,502	0	0	For
AQR	30,581	0	0	For
CLEARWATER INVESTMENT TRUST	30,175	0	0	For
Brighthouse	29,514	0	0	For
Nationwide	24,436	0	0	For
John Hancock	24,311	0	0	For
Bridge Builder Trust	19,177	0	0	For
Voya	17,395	0	0	For
ProShares	15,108	0	0	For
DWS	14,248	0	0	For
T. Rowe Price	11,619	0	0	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

10. Reelecting nominees to the Board of Directors: The board of directors proposes that Ron Squerer be reelected as the chair of the board of directors and a director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 65,109,377AGAINST: 416,194

ADC Therapeutics SA’s own tally for this item (“Elect Director: Ron Squarer”): 65,109,377 for, 416,194 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 51.2% for, 0.4% against (51.5% of the company cast a for/against vote).

The 36 asset managers below cast 99.9% of the shares they voted on this item FOR (11,543,623 for, 7,456 against).

FOR 99.9%

FOR: 11,543,623 (99.9%)AGAINST: 7,456 (0.1%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Ron Squerer be reelected a” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

11. Reelecting PricewaterhouseCoopers SA as the auditors The Board of Directors proposes that PricewaterhouseCoopers SA be reelected as the statutory auditor and independent registered public accounting firm for the year ending December 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 79,747,180AGAINST: 31,325

ADC Therapeutics SA’s own tally for this item (“Proposal #8 : Reelecting the auditors The shareholders reelected PricewaterhouseCoopers SA as the statutory auditor and independent registered public accounting firm for the year ending December 31, 2026.”): 79,747,180 for, 31,325 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 63% for, 0.1% against (63% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (11,551,079 for, 0 against).

FOR 100%

FOR: 11,551,079 (100.0%)

Largest asset managers voting on “Reelecting PricewaterhouseCoopers SA as the auditors The Board of Directors proposes that PricewaterhouseCoope” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
CLEARWATER INVESTMENT TRUST	30,175	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

12. THE BOARD OF DIRECTORS PROPOSES THAT THE MAXIMUM AGGREGATE AMOUNT OF FIXED COMPENSATION FOR THE MEMBERS OF THE EXECUTIVE COMMITTEE FOR THE YEAR ENDING DECEMBER 31, 2027, BE SET AT $2,600,000.

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 36 asset managers below cast 100% of the shares they voted on this item FOR (8,115,615 for, 0 against).

FOR: 8,115,615 (100.0%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT THE MAXIMUM AGGREGATE AMOUNT OF FIXED COMPENSATION FOR THE MEMBERS OF THE” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
DAFNA Capital Management LLC	72,081	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
Ethic Inc.	11,546	For
SEI	8,000	For
Calvert	6,859	For
Venerable Variable Insurance Trust	6,000	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

13. THE BOARD OF DIRECTORS PROPOSES THAT THE MAXIMUM AGGREGATE AMOUNT OF VARIABLE COMPENSATION FOR THE MEMBERS OF THE EXECUTIVE COMMITTEE FOR THE YEAR ENDING DECEMBER 31, 2026, BE SET AT $5,500,000.

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 36 asset managers below cast 100% of the shares they voted on this item FOR (8,115,615 for, 0 against).

FOR: 8,115,615 (100.0%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT THE MAXIMUM AGGREGATE AMOUNT OF VARIABLE COMPENSATION FOR THE MEMBERS OF ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
DAFNA Capital Management LLC	72,081	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
Ethic Inc.	11,546	For
SEI	8,000	For
Calvert	6,859	For
Venerable Variable Insurance Trust	6,000	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

14. Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors proposes that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved.

COMPENSATIONMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%AGAINST 29%

FOR: 46,624,648AGAINST: 18,904,924

ADC Therapeutics SA’s own tally for this item (“Proposal #11 : Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The shareholders approved an amendment to increase the number of shares authorized under the 2019 Equ”): 46,624,648 for, 18,904,924 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 37% for, 15% against (51.5% of the company cast a for/against vote).

The 35 asset managers below cast 49.5% of the shares they voted on this item FOR (5,701,655 for, 5,819,249 against).

FOR 49.5%AGAINST 50.5%

FOR: 5,701,655 (49.5%)AGAINST: 5,819,249 (50.5%)

Largest asset managers voting on “Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Bo” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	For
BlackRock	0	3,275,660	Against
Vanguard	0	1,086,732	Against
Charles Schwab	0	224,361	Against
Equitable	0	185,783	Against
QUANTITATIVE MASTER SERIES LLC	0	173,365	Against
TIAA	0	123,269	Against
State Street	0	115,544	Against
Russell Investments	0	90,968	Against
Fidelity	0	87,048	Against
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Global X	0	48,046	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
John Hancock	0	24,311	Against
Bridge Builder Trust	0	19,177	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	0	11,619	Against
SEI	0	8,000	Against

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

15. Approving the Company's management report, annual financial statements and consolidated financial statements for the year ended December 31, 2025 and acknowledging the Auditors' Reports for the year ended December 31, 2025. The Board of Directors proposes that the Management Report, the Annual Financial Statements and the Consolidated Financial Statements for the year ended December 31, 2025, be a

CORPORATE GOVERNANCE

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 35 asset managers below cast 100% of the shares they voted on this item FOR (11,520,904 for, 0 against).

FOR: 11,520,904 (100.0%)

Largest asset managers voting on “Approving the Company's management report, annual financial statements and consolidated financial statements f” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
SEI	8,000	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

16. Discharging the members of the Board of Directors and the Executive Committee from Liability for the year ended December 31, 2025. The Board of Directors proposes that the members of the Board of Directors and the Executive Committee be discharged from liability for the year ended December 31, 2025.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 63,695,590AGAINST: 86,523

ADC Therapeutics SA’s own tally for this item (“Proposal #3 : Discharging the members of the board of directors and the executive committee from liability The shareholders approved that the members of the board of directors and the executive committee be discharged fr”): 63,695,590 for, 86,523 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 50.1% for, 0.1% against (50.1% of the company cast a for/against vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (11,520,904 for, 0 against).

FOR 100%

FOR: 11,520,904 (100.0%)

Largest asset managers voting on “Discharging the members of the Board of Directors and the Executive Committee from Liability for the year ende” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	5,701,655	For
BlackRock	3,275,660	For
Vanguard	1,086,732	For
Charles Schwab	224,361	For
Equitable	185,783	For
QUANTITATIVE MASTER SERIES LLC	173,365	For
TIAA	123,269	For
State Street	115,544	For
Russell Investments	90,968	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Global X	48,046	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
John Hancock	24,311	For
Bridge Builder Trust	19,177	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
SEI	8,000	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

17. THE BOARD OF DIRECTORS PROPOSES THAT A NEW ARTICLE 4D BE INTRODUCED IN THE ARTICLES OF ASSOCIATION REGARDING A CONDITIONAL SHARE CAPITAL BASED ON THE CAPITAL RANGE, AND THAT ARTICLE 4A BE AMENDED ACCORDINGLY, TO PROVIDE FOR THE ISSUANCE OF UP TO 64,863,182 COMMON SHARES (CHF 5,189,054.56).

SHAREHOLDER RIGHTS AND DEFENSES

92% fund support · no official result

FOR 92%8%

The 31 asset managers below cast 92% of the shares they voted on this item FOR (12,577,687 for, 1,152,359 against).

FOR: 12,577,687 (91.6%)AGAINST: 1,152,359 (8.4%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT A NEW ARTICLE 4D BE INTRODUCED IN THE ARTICLES OF ASSOCIATION REGARDING A” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	11,403,310	0	For
Vanguard	1,086,732	0	For
Charles Schwab	0	224,361	Against
Equitable	0	185,783	Against
TIAA	0	123,269	Against
State Street	0	115,544	Against
Russell Investments	0	90,968	Against
Fidelity	87,048	0	For
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Global X	0	48,046	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	0	11,619	Against
SEI	0	8,000	Against
Calvert	0	6,859	Against
Venerable Variable Insurance Trust	0	6,000	Against
Brinker Capital Destinations Trust	0	3,124	Against
PENN SERIES FUNDS INC	0	2,600	Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

18. THE BOARD OF DIRECTORS PROPOSES THAT THE AMENDMENTS TO ARTICLE 4B PARAGRAPH 1 OF THE ARTICLES OF ASSOCIATION TO INCREASE THE COMPANY'S CONDITIONAL SHARE CAPITAL FOR EMPLOYEE PARTICIPATION FROM 9,887,629 COMMON SHARES (CHF 791,010.32) TO 16,836,253 COMMON SHARES (CHF 1,346,900.24) BE APPROVED.

SHAREHOLDER RIGHTS AND DEFENSES

85% fund support · no official result

FOR 85%AGAINST 15%

The 31 asset managers below cast 85% of the shares they voted on this item FOR (6,800,996 for, 1,227,395 against).

FOR: 6,800,996 (84.7%)AGAINST: 1,227,395 (15.3%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT THE AMENDMENTS TO ARTICLE 4B PARAGRAPH 1 OF THE ARTICLES OF ASSOCIATION T” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	For
Vanguard	1,086,732	0	For
Charles Schwab	0	224,361	Against
Equitable	0	185,783	Against
TIAA	0	123,269	Against
State Street	0	115,544	Against
Russell Investments	0	90,968	Against
Fidelity	0	87,048	Against
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Global X	0	48,046	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	11,619	0	For
SEI	0	8,000	Against
Calvert	0	6,859	Against
Venerable Variable Insurance Trust	0	6,000	Against
Brinker Capital Destinations Trust	0	3,124	Against
PENN SERIES FUNDS INC	0	2,600	Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

19. THE BOARD OF DIRECTORS PROPOSES THAT THE AMENDMENTS TO ARTICLE 4C PARAGRAPH 1 OF THE ARTICLES OF ASSOCIATION TO INCREASE THE COMPANY'S CONDITIONAL SHARE CAPITAL FOR FINANCING, ACQUISITIONS AND OTHER PURPOSES FROM 38,026,929 COMMON SHARES (CHF 3,042,154.32) TO 48,026,929 COMMON SHARES (CHF 3,842,154.32) BE APPROVED.

SHAREHOLDER RIGHTS AND DEFENSES

86% fund support · no official result

FOR 86%AGAINST 14%

The 31 asset managers below cast 86% of the shares they voted on this item FOR (6,876,032 for, 1,152,359 against).

FOR: 6,876,032 (85.6%)AGAINST: 1,152,359 (14.4%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT THE AMENDMENTS TO ARTICLE 4C PARAGRAPH 1 OF THE ARTICLES OF ASSOCIATION T” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	For
Vanguard	1,086,732	0	For
Charles Schwab	0	224,361	Against
Equitable	0	185,783	Against
TIAA	0	123,269	Against
State Street	0	115,544	Against
Russell Investments	0	90,968	Against
Fidelity	87,048	0	For
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Global X	0	48,046	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	0	11,619	Against
SEI	0	8,000	Against
Calvert	0	6,859	Against
Venerable Variable Insurance Trust	0	6,000	Against
Brinker Capital Destinations Trust	0	3,124	Against
PENN SERIES FUNDS INC	0	2,600	Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

20. Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2027 annual general meeting of Shareholders be set at $2,500,000.

COMPENSATIONMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST 26%

FOR: 48,456,972AGAINST: 16,977,874

ADC Therapeutics SA’s own tally for this item (“Proposal #9 : Approving, on a binding basis under Swiss law, the compensation of the board of directors and the executive committee The shareholders approved, on a binding basis under Swiss law, that (i) the maximum aggr”): 48,456,972 for, 16,977,874 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,191,158 outstanding shares: 38% for, 13% against (51.4% of the company cast a for/against vote).

The 29 asset managers below cast 63% of the shares they voted on this item FOR (6,999,097 for, 4,143,835 against).

FOR 63%AGAINST 37%

FOR: 6,999,097 (62.8%)AGAINST: 4,143,835 (37.2%)

Largest asset managers voting on “Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Co” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	For
BlackRock	0	3,275,660	Against
Vanguard	1,086,732	0	For
Equitable	0	185,783	Against
QUANTITATIVE MASTER SERIES LLC	0	173,365	Against
TIAA	123,269	0	For
State Street	0	115,544	Against
Fidelity	87,048	0	For
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
John Hancock	0	24,311	Against
Bridge Builder Trust	0	19,177	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	0	11,619	Against
Calvert	0	6,859	Against
Brinker Capital Destinations Trust	0	3,124	Against
PENN SERIES FUNDS INC	0	2,600	Against
Morgan Stanley	0	2,526	Against

Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.

21. Other Business

CORPORATE GOVERNANCE

0.1% fund support · no official result

AGAINST 99.9%

The 26 asset managers below cast 0.1% of the shares they voted on this item FOR (393 for, 7,680,201 against).

FOR: 393 (0.0%)AGAINST: 7,680,201 (100.0%)

Largest asset managers voting on “Other Business” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	0	5,701,655	Against
Vanguard	0	1,086,732	Against
Equitable	0	185,783	Against
TIAA	0	123,269	Against
State Street	0	115,544	Against
Fidelity	0	87,048	Against
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
CLEARWATER INVESTMENT TRUST	0	30,175	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	0	11,619	Against
Calvert	0	6,859	Against
Brinker Capital Destinations Trust	0	3,124	Against
PENN SERIES FUNDS INC	0	2,600	Against
Morgan Stanley	0	2,526	Against
Blackstone Alternative Investment Funds	0	2,491	Against
Guggenheim	0	660	Against
Goldman Sachs	393	0	For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

22. Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range. The

CAPITAL STRUCTURE

Combines 2 wordings of this item as funds reported it.

90% fund support · no official result

FOR 90%10%

The 25 asset managers below cast 90% of the shares they voted on this item FOR (6,875,828 for, 774,591 against).

FOR: 6,875,828 (89.9%)AGAINST: 774,591 (10.1%)

Largest asset managers voting on “Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capita” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	5,701,655	0	For
Vanguard	1,086,732	0	For
Equitable	0	185,783	Against
TIAA	0	123,269	Against
State Street	0	115,544	Against
Fidelity	87,048	0	For
Lincoln Financial	0	53,800	Against
AIG/SunAmerica	0	52,249	Against
Northern Trust	0	48,191	Against
Pacific Life	0	34,502	Against
AQR	0	30,581	Against
Brighthouse	0	29,514	Against
Nationwide	0	24,436	Against
Voya	0	17,395	Against
ProShares	0	15,108	Against
DWS	0	14,248	Against
T. Rowe Price	0	11,619	Against
Calvert	0	6,859	Against
Brinker Capital Destinations Trust	0	3,124	Against
PENN SERIES FUNDS INC	0	2,600	Against
Morgan Stanley	0	2,526	Against
Blackstone Alternative Investment Funds	0	2,491	Against
Guggenheim	0	660	Against
Goldman Sachs	393	0	For
Columbia Threadneedle	0	92	Against

23. Reelecting nominees to the Board of Directors: The board of directors proposes that Peter Hug be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONS

93% fund support · no official result

FOR 92%

The 24 asset managers below cast 93% of the shares they voted on this item FOR (1,793,316 for, 130,128 against).

FOR: 1,793,316 (92.0%)AGAINST: 130,128 (6.7%)ABSTAIN: 25,320 (1.3%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Peter Hug be reelected as ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	1,086,732	0	0	For
Equitable	160,463	0	25,320	For
TIAA	0	123,269	0	Against
State Street	115,544	0	0	For
Fidelity	87,048	0	0	For
Lincoln Financial	53,800	0	0	For
AIG/SunAmerica	52,249	0	0	For
Northern Trust	48,191	0	0	For
Pacific Life	34,502	0	0	For
AQR	30,581	0	0	For
Brighthouse	29,514	0	0	For
Nationwide	24,436	0	0	For
Voya	17,395	0	0	For
ProShares	15,108	0	0	For
DWS	14,248	0	0	For
T. Rowe Price	11,619	0	0	For
Calvert	0	6,859	0	Against
Brinker Capital Destinations Trust	3,124	0	0	For
PENN SERIES FUNDS INC	2,600	0	0	For
Morgan Stanley	2,526	0	0	For
Blackstone Alternative Investment Funds	2,491	0	0	For
Guggenheim	660	0	0	For
Goldman Sachs	393	0	0	For
Columbia Threadneedle	92	0	0	For

24. Reelecting nominees to the Board of Directors: The board of directors proposes that Robert Azelby be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 24 asset managers below cast 100% of the shares they voted on this item FOR (1,948,764 for, 0 against).

FOR: 1,948,764 (100.0%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Robert Azelby be reelected” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
Vanguard	1,086,732	For
Equitable	185,783	For
TIAA	123,269	For
State Street	115,544	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
Calvert	6,859	For
Brinker Capital Destinations Trust	3,124	For
PENN SERIES FUNDS INC	2,600	For
Morgan Stanley	2,526	For
Blackstone Alternative Investment Funds	2,491	For
Guggenheim	660	For
Goldman Sachs	393	For
Columbia Threadneedle	92	For

25. Reelecting nominees to the Board of Directors: The board of directors proposes that Victor Sandor be reelected as director for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of shareholders.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 24 asset managers below cast 100% of the shares they voted on this item FOR (1,948,764 for, 0 against).

FOR: 1,948,764 (100.0%)

Largest asset managers voting on “Reelecting nominees to the Board of Directors: The board of directors proposes that Victor Sandor be reelected” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
Vanguard	1,086,732	For
Equitable	185,783	For
TIAA	123,269	For
State Street	115,544	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
Calvert	6,859	For
Brinker Capital Destinations Trust	3,124	For
PENN SERIES FUNDS INC	2,600	For
Morgan Stanley	2,526	For
Blackstone Alternative Investment Funds	2,491	For
Guggenheim	660	For
Goldman Sachs	393	For
Columbia Threadneedle	92	For

26. Reelecting nominees to the Compensation Committee of the Board of Directors: The board of directors proposes that Peter Hug be reelected as a member of the Compensation Committee for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of Shareholders.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

93% fund support · no official result

FOR 92%

The 24 asset managers below cast 93% of the shares they voted on this item FOR (1,793,316 for, 130,128 against).

FOR: 1,793,316 (92.0%)AGAINST: 130,128 (6.7%)ABSTAIN: 25,320 (1.3%)

Largest asset managers voting on “Reelecting nominees to the Compensation Committee of the Board of Directors: The board of directors proposes t” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Abstain	Vote
Vanguard	1,086,732	0	0	For
Equitable	160,463	0	25,320	For
TIAA	0	123,269	0	Against
State Street	115,544	0	0	For
Fidelity	87,048	0	0	For
Lincoln Financial	53,800	0	0	For
AIG/SunAmerica	52,249	0	0	For
Northern Trust	48,191	0	0	For
Pacific Life	34,502	0	0	For
AQR	30,581	0	0	For
Brighthouse	29,514	0	0	For
Nationwide	24,436	0	0	For
Voya	17,395	0	0	For
ProShares	15,108	0	0	For
DWS	14,248	0	0	For
T. Rowe Price	11,619	0	0	For
Calvert	0	6,859	0	Against
Brinker Capital Destinations Trust	3,124	0	0	For
PENN SERIES FUNDS INC	2,600	0	0	For
Morgan Stanley	2,526	0	0	For
Blackstone Alternative Investment Funds	2,491	0	0	For
Guggenheim	660	0	0	For
Goldman Sachs	393	0	0	For
Columbia Threadneedle	92	0	0	For

27. Reelecting nominees to the Compensation Committee of the Board of Directors: The board of directors proposes that Robert Azelby be reelected as a member of the compensation committee for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of Shareholders.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

100% fund support · no official result

FOR 100%

The 24 asset managers below cast 100% of the shares they voted on this item FOR (1,948,764 for, 0 against).

FOR: 1,948,764 (100.0%)

Largest asset managers voting on “Reelecting nominees to the Compensation Committee of the Board of Directors: The board of directors proposes t” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
Vanguard	1,086,732	For
Equitable	185,783	For
TIAA	123,269	For
State Street	115,544	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
Calvert	6,859	For
Brinker Capital Destinations Trust	3,124	For
PENN SERIES FUNDS INC	2,600	For
Morgan Stanley	2,526	For
Blackstone Alternative Investment Funds	2,491	For
Guggenheim	660	For
Goldman Sachs	393	For
Columbia Threadneedle	92	For

28. Reelecting nominees to the Compensation Committee of the Board of Directors: The board of directors proposes that Victor Sandor be reelected as a member of the Compensation Committee for a one-year term, beginning as of the Annual Meeting and ending at the closing of the 2027 annual general meeting of Shareholders.

DIRECTOR ELECTIONSCORPORATE GOVERNANCE

100% fund support · no official result

FOR 100%

The 24 asset managers below cast 100% of the shares they voted on this item FOR (1,948,764 for, 0 against).

FOR: 1,948,764 (100.0%)

Largest asset managers voting on “Reelecting nominees to the Compensation Committee of the Board of Directors: The board of directors proposes t” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
Vanguard	1,086,732	For
Equitable	185,783	For
TIAA	123,269	For
State Street	115,544	For
Fidelity	87,048	For
Lincoln Financial	53,800	For
AIG/SunAmerica	52,249	For
Northern Trust	48,191	For
Pacific Life	34,502	For
AQR	30,581	For
Brighthouse	29,514	For
Nationwide	24,436	For
Voya	17,395	For
ProShares	15,108	For
DWS	14,248	For
T. Rowe Price	11,619	For
Calvert	6,859	For
Brinker Capital Destinations Trust	3,124	For
PENN SERIES FUNDS INC	2,600	For
Morgan Stanley	2,526	For
Blackstone Alternative Investment Funds	2,491	For
Guggenheim	660	For
Goldman Sachs	393	For
Columbia Threadneedle	92	For

29. THE BOARD OF DIRECTORS PROPOSES THAT PETER HUG BE REELECTED AS A MEMBER OF THE COMPENSATION COMMITTEE FOR A ONE-YEAR TERM, BEGINNING AS OF THE ANNUAL MEETING AND ENDING AT THE CLOSING OF THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

DIRECTOR ELECTIONS

99.8% fund support · no official result

FOR 99.8%

The 6 asset managers below cast 99.8% of the shares they voted on this item FOR (377,375 for, 597 against).

FOR: 377,375 (99.8%)AGAINST: 597 (0.2%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT PETER HUG BE REELECTED AS A MEMBER OF THE COMPENSATION COMMITTEE FOR A ON” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
Charles Schwab	224,361	0	For
Russell Investments	90,968	0	For
Global X	48,046	0	For
SEI	8,000	0	For
Venerable Variable Insurance Trust	6,000	0	For
Advisors' Inner Circle Fund III	0	597	Against

30. THE BOARD OF DIRECTORS PROPOSES THAT PETER HUG BE REELECTED AS DIRECTOR FOR A ONE-YEAR TERM, BEGINNING AS OF THE ANNUAL MEETING AND ENDING AT THE CLOSING OF THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

DIRECTOR ELECTIONS

99.8% fund support · no official result

FOR 99.8%

The 6 asset managers below cast 99.8% of the shares they voted on this item FOR (377,375 for, 597 against).

FOR: 377,375 (99.8%)AGAINST: 597 (0.2%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT PETER HUG BE REELECTED AS DIRECTOR FOR A ONE-YEAR TERM, BEGINNING AS OF T” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
Charles Schwab	224,361	0	For
Russell Investments	90,968	0	For
Global X	48,046	0	For
SEI	8,000	0	For
Venerable Variable Insurance Trust	6,000	0	For
Advisors' Inner Circle Fund III	0	597	Against

31. THE BOARD OF DIRECTORS PROPOSES THAT ROBERT AZELBY BE REELECTED AS A MEMBER OF THE COMPENSATION COMMITTEE FOR A ONE-YEAR TERM, BEGINNING AS OF THE ANNUAL MEETING AND ENDING AT THE CLOSING OF THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 6 asset managers below cast 100% of the shares they voted on this item FOR (377,972 for, 0 against).

FOR: 377,972 (100.0%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT ROBERT AZELBY BE REELECTED AS A MEMBER OF THE COMPENSATION COMMITTEE FOR ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
Charles Schwab	224,361	For
Russell Investments	90,968	For
Global X	48,046	For
SEI	8,000	For
Venerable Variable Insurance Trust	6,000	For
Advisors' Inner Circle Fund III	597	For

32. THE BOARD OF DIRECTORS PROPOSES THAT ROBERT AZELBY BE REELECTED AS DIRECTOR FOR A ONE-YEAR TERM, BEGINNING AS OF THE ANNUAL MEETING AND ENDING AT THE CLOSING OF THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 6 asset managers below cast 100% of the shares they voted on this item FOR (377,972 for, 0 against).

FOR: 377,972 (100.0%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT ROBERT AZELBY BE REELECTED AS DIRECTOR FOR A ONE-YEAR TERM, BEGINNING AS ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Vote
Charles Schwab	224,361	For
Russell Investments	90,968	For
Global X	48,046	For
SEI	8,000	For
Venerable Variable Insurance Trust	6,000	For
Advisors' Inner Circle Fund III	597	For

33. THE BOARD OF DIRECTORS PROPOSES THAT THE AMENDMENTS TO ARTICLE 4A PARAGRAPH 1 OF THE ARTICLES OF ASSOCIATION TO INCREASE THE COMPANY'S CAPITAL RANGE FROM CHF 8,375,974.48 (LOWER LIMIT) AND CHF 12,354,128.80 (UPPER LIMIT) TO CHF 10,378,109.12 (LOWER LIMIT) AND CHF 15,567,163.68 (UPPER LIMIT) BE APPROVED.

SHAREHOLDER RIGHTS AND DEFENSES

0.2% fund support · no official result

AGAINST 99.8%

The 6 asset managers below cast 0.2% of the shares they voted on this item FOR (597 for, 377,375 against).

FOR: 597 (0.2%)AGAINST: 377,375 (99.8%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT THE AMENDMENTS TO ARTICLE 4A PARAGRAPH 1 OF THE ARTICLES OF ASSOCIATION T” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
Charles Schwab	0	224,361	Against
Russell Investments	0	90,968	Against
Global X	0	48,046	Against
SEI	0	8,000	Against
Venerable Variable Insurance Trust	0	6,000	Against
Advisors' Inner Circle Fund III	597	0	For

34. THE BOARD OF DIRECTORS PROPOSES THAT THE MAXIMUM AGGREGATE AMOUNT OF COMPENSATION FOR THE MEMBERS OF THE BOARD OF DIRECTORS FOR THE PERIOD BETWEEN THE ANNUAL MEETING AND THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS BE SET AT $2,500,000.

COMPENSATION

0.2% fund support · no official result

AGAINST 99.8%

The 6 asset managers below cast 0.2% of the shares they voted on this item FOR (597 for, 377,375 against).

FOR: 597 (0.2%)AGAINST: 377,375 (99.8%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT THE MAXIMUM AGGREGATE AMOUNT OF COMPENSATION FOR THE MEMBERS OF THE BOARD” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
Charles Schwab	0	224,361	Against
Russell Investments	0	90,968	Against
Global X	0	48,046	Against
SEI	0	8,000	Against
Venerable Variable Insurance Trust	0	6,000	Against
Advisors' Inner Circle Fund III	597	0	For

35. THE BOARD OF DIRECTORS PROPOSES THAT VICTOR SANDOR BE REELECTED AS A MEMBER OF THE COMPENSATION COMMITTEE FOR A ONE-YEAR TERM, BEGINNING AS OF THE ANNUAL MEETING AND ENDING AT THE CLOSING OF THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

DIRECTOR ELECTIONS

99.8% fund support · no official result

FOR 99.8%

The 6 asset managers below cast 99.8% of the shares they voted on this item FOR (377,375 for, 597 against).

FOR: 377,375 (99.8%)AGAINST: 597 (0.2%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT VICTOR SANDOR BE REELECTED AS A MEMBER OF THE COMPENSATION COMMITTEE FOR ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
Charles Schwab	224,361	0	For
Russell Investments	90,968	0	For
Global X	48,046	0	For
SEI	8,000	0	For
Venerable Variable Insurance Trust	6,000	0	For
Advisors' Inner Circle Fund III	0	597	Against

36. THE BOARD OF DIRECTORS PROPOSES THAT VICTOR SANDOR BE REELECTED AS DIRECTOR FOR A ONE-YEAR TERM, BEGINNING AS OF THE ANNUAL MEETING AND ENDING AT THE CLOSING OF THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.

DIRECTOR ELECTIONS

99.8% fund support · no official result

FOR 99.8%

The 6 asset managers below cast 99.8% of the shares they voted on this item FOR (377,375 for, 597 against).

FOR: 377,375 (99.8%)AGAINST: 597 (0.2%)

Largest asset managers voting on “THE BOARD OF DIRECTORS PROPOSES THAT VICTOR SANDOR BE REELECTED AS DIRECTOR FOR A ONE-YEAR TERM, BEGINNING AS ” at ADC Therapeutics SA, 2025-2026
Asset manager	For	Against	Vote
Charles Schwab	224,361	0	For
Russell Investments	90,968	0	For
Global X	48,046	0	For
SEI	8,000	0	For
Venerable Variable Insurance Trust	6,000	0	For
Advisors' Inner Circle Fund III	0	597	Against

37. Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range. - Pr

CAPITAL STRUCTURE

0% fund support · no official result

AGAINST 100%

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 3,492,513 against).

AGAINST: 3,492,513 (100.0%)

Largest asset managers voting on “Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capita” at ADC Therapeutics SA, 2025-2026
Asset manager	Against	Vote
BlackRock	3,275,660	Against
QUANTITATIVE MASTER SERIES LLC	173,365	Against
John Hancock	24,311	Against
Bridge Builder Trust	19,177	Against

38. Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range. - Pr

CAPITAL STRUCTURE

0% fund support · no official result

AGAINST 100%

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 3,492,513 against).

AGAINST: 3,492,513 (100.0%)

Largest asset managers voting on “Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capita” at ADC Therapeutics SA, 2025-2026
Asset manager	Against	Vote
BlackRock	3,275,660	Against
QUANTITATIVE MASTER SERIES LLC	173,365	Against
John Hancock	24,311	Against
Bridge Builder Trust	19,177	Against

39. Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range. - Pr

CAPITAL STRUCTURE

0% fund support · no official result

AGAINST 100%

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 3,492,513 against).

AGAINST: 3,492,513 (100.0%)

Largest asset managers voting on “Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capita” at ADC Therapeutics SA, 2025-2026
Asset manager	Against	Vote
BlackRock	3,275,660	Against
QUANTITATIVE MASTER SERIES LLC	173,365	Against
John Hancock	24,311	Against
Bridge Builder Trust	19,177	Against

40. Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range. - Pr

CAPITAL STRUCTURE

0% fund support · no official result

AGAINST 100%

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 3,492,513 against).

AGAINST: 3,492,513 (100.0%)

Largest asset managers voting on “Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company's capita” at ADC Therapeutics SA, 2025-2026
Asset manager	Against	Vote
BlackRock	3,275,660	Against
QUANTITATIVE MASTER SERIES LLC	173,365	Against
John Hancock	24,311	Against
Bridge Builder Trust	19,177	Against

Showing the 40 reported items with the widest manager coverage, of 48 in total. View every item.

Largest ADC Therapeutics SA shareholders voting in 2025-2026

Ranked by the number of ADC Therapeutics SA shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 127,191,158 shares outstanding at the time of that meeting.

Top ADC Therapeutics SA shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Redmile Group, LLC	9.97%
2	BlackRock	4.59%
3	MUTUAL FUND SERIES TRUST	4.48%
4	Prosight Management, LP	2.78%
5	Point72	2.56%
6	OAKTREE CAPITAL MANAGEMENT LP	2.06%
7	Caligan Partners LP	1.42%
8	State Street	1.08%
9	Vanguard	0.95%
10	Oaktree Fund Advisors, LLC	0.93%

Reported ADC Therapeutics SA ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ADC Therapeutics SA beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Redmile Group, LLC	10.00%	13G
Nantahala Capital Management, LLC	9.69%	13G
TCG Crossover GP II, LLC	8.96%	13G
Hans-Peter Wild	7.70%	DEF14A
Prosight Management, LP	6.67%	13G
BlackRock	4.91%	13F
Morgan Stanley	2.96%	13F
Point72	2.68%	13F
Ameet Mallik	1.84%	DEF14A
Goldman Sachs	1.30%	13F

Percentages above are of 127,191,158 shares outstanding, as reported by ADC Therapeutics SA on its Form 10-Q dated 2026-04-27 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADC Therapeutics SA’s 10-Q dated 2026-04-27. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ADC Therapeutics SA's shareholder meeting held 2026-06-01, in the 2025-2026 proxy season, 122 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,191 separate fund positions. Their filings are grouped here into 48 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ADC Therapeutics SA's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

ADC Therapeutics SA proxy season coverage: 2025-2026 (this page).